BEXIMCO PHARMAGDR (Germany) Today
| R2WA Stock | EUR 0.41 0.01 2.50% |
Performance19 of 100
| Odds Of DistressLess than 9
|
BEXIMCO PHARMAGDR is trading at 0.41 as of the 11th of December 2024. This is a 2.50% up since the beginning of the trading day. The stock's lowest day price was 0.41. BEXIMCO PHARMAGDR has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 14th of June 2024 and ending today, the 11th of December 2024. Click here to learn more.
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh. Beximco Pharmaceuticals operates under Drug Manufacturers - Major classification in Germany and traded on Frankfurt Stock Exchange.. The company has 446.11 M outstanding shares. More on BEXIMCO PHARMAGDR REGS
Moving together with BEXIMCO Stock
Moving against BEXIMCO Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BEXIMCO Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BEXIMCO PHARMAGDR's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BEXIMCO PHARMAGDR or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
BEXIMCO PHARMAGDR REGS (R2WA) is traded on Frankfurt Exchange in Germany and employs 5,500 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 563.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BEXIMCO PHARMAGDR's market, we take the total number of its shares issued and multiply it by BEXIMCO PHARMAGDR's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BEXIMCO PHARMAGDR REGS operates under Healthcare sector and is part of Drug Manufacturers-Specialty & Generic industry. The entity has 446.11 M outstanding shares.
Check BEXIMCO PHARMAGDR Probability Of Bankruptcy
Ownership AllocationBEXIMCO PHARMAGDR holds a total of 446.11 Million outstanding shares. Almost 97.91 percent of BEXIMCO PHARMAGDR outstanding shares are held by general public with 2.09 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BEXIMCO Ownership Details
BEXIMCO PHARMAGDR REGS Risk Profiles
Although BEXIMCO PHARMAGDR's alpha and beta are two of the key measurements used to evaluate BEXIMCO PHARMAGDR's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.82 | |||
| Semi Deviation | 2.34 | |||
| Standard Deviation | 4.37 | |||
| Variance | 19.11 |
BEXIMCO Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BEXIMCO PHARMAGDR without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Other Information on Investing in BEXIMCO Stock
BEXIMCO PHARMAGDR financial ratios help investors to determine whether BEXIMCO Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BEXIMCO with respect to the benefits of owning BEXIMCO PHARMAGDR security.